RxEOB

RxEOB supports millions of #healthplan members & #PBMs We help with member activation and predictive analytics to drive better outcomes! #Healthcare

[RxEOB @RxEOBcom]

RxEOB presented at the #NCPDP24 annual conference, Innovation & Connection Hub on the #RxWallet product innovation. Please visit https://t.co/ocAetN6IAu to see our newest video on how this product can help your members. #engagement #HealthcareInnovation #consumerism

[RxEOB @RxEOBcom]

Medicines save lives, but only if patients can afford to take them. A quarter of adults taking prescription medications say they have a hard time paying for them. #RxWallet seeks to change that. https://t.co/ocAetN6aKW #HealthcareFinance #consumerism https://t.co/Vq26AkPTqD

[RxEOB @RxEOBcom]

This caught me by surprise, but I guess what was old is new again. In 2023, roughly 7 percent of adults 65 and older reported using marijuana. That share is up from 4.8 percent in 2021. #healthcare #cannabis #AARP https://t.co/kng4HbuKMr

[RxEOB @RxEOBcom]

About three in ten adults report not taking their medicines as prescribed at some point in the past year because of the cost according to KFF research. #RxWallet can help! #HealthcareFinance #consumerism https://t.co/OCES2l5nJ9

[RxEOB @RxEOBcom]

We would like to wish everyone a safe, peaceful, and happy holiday weekend! #memorialday #honorandremember #wearegrateful

[RxEOB @RxEOBcom]

The U.S. spent more than $722 billion on prescription drugs in 2023, a 13.6% increase from 2022. This is the largest uptick in spending in 20 years, these are the top 25 medications driving the spending. #HealthcareFinance # consumerism #RxWallet https://t.co/lHxZFK1IQN

[RxEOB @RxEOBcom]

With only one of the industry’s top 20 revenue companies seeing a year-over-year decline in sales, 2024 was a remarkable year for the industry. Finding value is a challenge for patients. #consumerism #RxWallet #drugs https://t.co/ayVc4ycuL8

[RxEOB @RxEOBcom]

On Jan. 6, 2025, the HHS proposed new regulations to enhance cybersecurity protections for ePHI under HIPAA. After analyzing the proposed rule, here are the Top 10 key takeaways. #healthplans #HealthcareIT #DataPrivacy https://t.co/3athjhi8Gx

[RxEOB @RxEOBcom]

Had a wonderful time at the Gateway conference networking, learning, and exploring growth strategy possibilities! #RxEOB #RxWallet #hcldr

[RxEOB @RxEOBcom]

Manufacturers are jumping into the Direct to Consumer market. Consumers are driving the marketplace and #RxWallet can help! #engagement #consumerism https://t.co/zugsPatmY2

[RxEOB @RxEOBcom]

Looking forward to the opportunity to learn, share, enhance existing business relationships, and grow new ones at the upcoming Gateway and #NCPDP25 Conferences! Reach out if you will be in attendance and would like to meet. #RxWallet #hcldr

[RxEOB @RxEOBcom]

Although the report shows some successes, the true potential of biosimilars on the Pharmacy side of benefits has yet to be realized. The biosimilars market presents a multifaceted problem. #Healthplans #PBMs #HealthcareInnovation https://t.co/JxA0ar0zd7

[RxEOB @RxEOBcom]

Improving the marketplace or creating new barriers? The National Association of Attorneys General issued a letter to Congress calling for prohibition of PBM's ability to own & operate affiliated pharmacy businesses. #PBMs #HealthcareFinance #consumerism https://t.co/naQ6wngmRg

[RxEOB @RxEOBcom]

At the #AMCP2025 annual meeting in Houston Doug Long, VP of Industry Relations at IQVIA, noted with 170 GLP-1s that are in the pipeline, the market shows no signs of slowing down. Pharmacy spend challenges will continue. #healthcare #HealthcareFinance https://t.co/kKZh8TWitT

[RxEOB @RxEOBcom]

Accenture identifies the challenge of creating systems to monitor AI performance, security vulnerabilities & recommends that providers partner with diverse technology partners to leverage and scale gen AI across their organizations. #HiTrust #HealthcareIT https://t.co/1NaffWTkFj

[RxEOB @RxEOBcom]

We're excited to attend #AMCP2025 in Houston next week, & look forward to addressing industry interest in patient communications & workflow. If you will be there and would like to meet, please reach out to me on LinkedIn or by email at [email protected]! #RxWallet #MercuryMessaging

[RxEOB @RxEOBcom]

#InsideRx discounts are now available in the #RxWallet mobile application! Please visit us at https://t.co/ocAetN6aKW to learn more about how we can help empower your members to become smart e-prescription shoppers! https://t.co/7s6SaL0Fio

[RxEOB @RxEOBcom]

Pricing transparency is the focus for the people who should be making the decisions, patients & doctors. RxEOB brings price transparency through #RxWallet. #HealthcareInnovation #HealthcareFinance #consumerism https://t.co/Q6bFN4aMpd

[RxEOB @RxEOBcom]

Compounded GLP 1 pharmacies are in a fight for survival. Public policy regarding drug distribution will never be the same as the pre-Covid era. Helping people access care is becoming complicated. #RxWallet can help! #healthplans #PBMs #consumerism https://t.co/rnXLZhyI5E

[RxEOB @RxEOBcom]

Is it good or bad that the Trump and Biden Administrations agree on a significant drug pricing policy? Drug pricing matters. See how https://t.co/oJtlAyTpNb can help. #PBMs #engagement #consumerism https://t.co/UnDBQR0lHT

[RxEOB @RxEOBcom]

When Zolgensma hit the market it was hailed as a miracle drug. It helped reduce US death rates from SMA, the leading genetic cause of infant mortality, by 2/3rds. The journey to its pricing was more complicated. #healthcare #HealthcareFinance #consumerism https://t.co/mcS6czhHgn